Patents by Inventor Beth DROLET

Beth DROLET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF INFANTILE HEMANGIOMA
    Publication number: 20260256801
    Abstract: Transdermal delivery of beta blockers to treat Infantile Hemangiomas.
    Type: Application
    Filed: April 20, 2026
    Publication date: September 3, 2026
    Inventors: Thomas M. ROSSI, Beth DROLET, Agis KYDONIEUS
  • Treatment of infantile hemangioma
    Patent number: 12629378
    Abstract: Transdermal delivery of beta blockers to treat Infantile Hemangiomas (IH) with reduced systemic circulation of the active drug and reduced or eliminated drug exposure to internal organs. In some embodiments, the beta blocker is esmolol. Pharmaceutical compositions according to the invention may be formulated lotions, creams, ointments, gels, foams, liquid dispersions, solutions, or aerosols.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: May 19, 2026
    Assignee: ARKAYLI BIOPHARMA INC.
    Inventors: Thomas M. Rossi, Beth Drolet, Agis Kydonieus
  • TREATMENT OF INFANTILE HEMANGIOMA
    Publication number: 20220218716
    Abstract: Transdermal delivery of beta blockers to treat Infantile Hemangiomas.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 14, 2022
    Inventors: Thomas M. ROSSI, Beth DROLET, Agis KYDONIEUS